// App-Quantinova.ai

4111 : The Early Induction of PDL1 On Monocytes by Ivig Suppresses T Cell Activation in Allogeneic Mixed Lymphocyte Reactions

Researchers

Presenter

  • Renee Bazin

Principal Investigators

  • N/A

Medical Centers

  • Biochemistry, Microbiology and Bioinformatics, Laval University, Quebec, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 14

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 40

  • Programmed death-ligand 1

  • Cluster of differentiation 86

  • Human Leukocyte Antigen – DR isotype

  • Interleukin-2

  • T-cell receptor

Drug/Treatment

  • IVIG

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim